Roffman Miller Associates Inc Merck & Co., Inc. Transaction History

Roffman Miller Associates Inc

  • $1.63 Billion
  • Q4 2024

A detailed history of Roffman Miller Associates Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Roffman Miller Associates Inc holds 194,207 shares of MRK stock, worth $18.1 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares
194,207
Previous 228,733 15.09%
Holding current value
$18.1 Million
Previous $26 Million 25.62%
% of portfolio
1.19%
Previous 1.59%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025
SELL
$96.31 - $114.76 $3.33 Million - $3.96 Million
-34,526 Reduced 15.09%
194,207 $19.3 Million
Q3 2024

Nov 15, 2024
SELL
$111.15 - $128.97 $2.77 Million - $3.22 Million
-24,939 Reduced 9.83%
228,733 $26 Million
Q2 2024

Jul 30, 2024
BUY
$123.8 - $132.96 $462,393 - $496,605
3,735 Added 1.49%
253,672 $31.4 Million
Q1 2024

May 07, 2024
SELL
$113.24 - $131.95 $159,894 - $186,313
-1,412 Reduced 0.56%
249,937 $33 Million
Q4 2023

Feb 02, 2024
BUY
$100.18 - $109.02 $1.24 Million - $1.35 Million
12,364 Added 5.17%
251,349 $27.4 Million
Q3 2023

Nov 09, 2023
BUY
$102.95 - $114.33 $645,805 - $717,192
6,273 Added 2.7%
238,985 $24.6 Million
Q2 2023

Aug 07, 2023
SELL
$108.61 - $118.38 $770,370 - $839,669
-7,093 Reduced 2.96%
232,712 $26.9 Million
Q1 2023

May 10, 2023
BUY
$102.94 - $114.86 $131,969 - $147,250
1,282 Added 0.54%
239,805 $25.5 Million
Q4 2022

Jan 17, 2023
BUY
$87.44 - $112.11 $346,612 - $444,404
3,964 Added 1.69%
238,523 $0
Q3 2022

Nov 07, 2022
BUY
$84.53 - $94.96 $243,446 - $273,484
2,880 Added 1.24%
234,559 $20.2 Million
Q2 2022

Aug 08, 2022
SELL
$83.49 - $94.64 $856,857 - $971,290
-10,263 Reduced 4.24%
231,679 $21.1 Million
Q1 2022

May 24, 2022
BUY
$73.51 - $82.4 $12,643 - $14,172
172 Added 0.07%
241,942 $19.9 Million
Q4 2021

Feb 03, 2022
BUY
$72.28 - $90.54 $720,053 - $901,959
9,962 Added 4.3%
241,770 $18.5 Million
Q3 2021

Nov 15, 2021
SELL
$71.68 - $78.83 $4.49 Million - $4.94 Million
-62,656 Reduced 21.28%
231,808 $17.4 Million
Q2 2021

Aug 06, 2021
BUY
$70.31 - $77.77 $768,066 - $849,559
10,924 Added 3.85%
294,464 $22.9 Million
Q1 2021

Apr 16, 2021
BUY
$68.86 - $81.11 $2.33 Million - $2.75 Million
33,867 Added 13.56%
283,540 $16.3 Million
Q4 2020

Feb 16, 2021
BUY
$71.77 - $79.65 $6.52 Million - $7.24 Million
90,898 Added 57.25%
249,673 $14.6 Million
Q3 2020

Nov 06, 2020
BUY
$73.18 - $82.95 $1.45 Million - $1.65 Million
19,849 Added 14.29%
158,775 $13.2 Million
Q2 2020

Nov 06, 2020
BUY
$70.42 - $80.13 $1.65 Million - $1.88 Million
23,418 Added 20.27%
138,926 $10.3 Million
Q1 2020

May 14, 2020
BUY
$63.36 - $87.82 $1.86 Million - $2.58 Million
29,434 Added 34.2%
115,508 $8.89 Million
Q4 2019

Jan 24, 2020
BUY
$77.58 - $87.54 $3.09 Million - $3.49 Million
39,812 Added 86.06%
86,074 $7.83 Million
Q3 2019

Nov 04, 2019
SELL
$76.08 - $82.93 $1.87 Million - $2.04 Million
-24,644 Closed
0 $0
Q2 2019

Aug 09, 2019
BUY
$69.84 - $81.59 $141,635 - $165,464
2,028 Added 8.97%
24,644 $2.07 Million
Q1 2019

May 15, 2019
BUY
$69.58 - $79.36 $1.57 Million - $1.79 Million
22,616 New
22,616 $1.87 Million
Q4 2018

Feb 11, 2019
SELL
$65.24 - $75.71 $1.4 Million - $1.63 Million
-21,521 Closed
0 $0
Q3 2018

Nov 06, 2018
BUY
$57.69 - $67.84 $276,854 - $325,564
4,799 Added 28.7%
21,521 $1.53 Million
Q2 2018

Aug 07, 2018
BUY
$50.83 - $59.72 $100,592 - $118,185
1,979 Added 13.42%
16,722 $1.02 Million
Q1 2018

May 01, 2018
SELL
$50.96 - $59.23 $56,310 - $65,449
-1,105 Reduced 6.97%
14,743 $803,000
Q4 2017

Feb 06, 2018
BUY
$51.62 - $61.64 $6,555 - $7,828
127 Added 0.81%
15,848 $892,000
Q3 2017

Nov 03, 2017
BUY
$58.67 - $63.13 $922,351 - $992,466
15,721
15,721 $1.01 Million

Others Institutions Holding MRK

# of Institutions
3,964
Shares Held
1.94B
Call Options Held
16M
Put Options Held
15M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $236B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Roffman Miller Associates Inc Portfolio

Follow Roffman Miller Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roffman Miller Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Roffman Miller Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email